OVB logo

Ovoca Bio plc Stock Price

AIM:OVB Community·UK£938.0k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

OVB Share Price Performance

UK£0.011
-0.00 (-28.13%)
UK£0.011
-0.00 (-28.13%)
Price UK£0.011

OVB Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet moderate.

5 Risks
0 Rewards

Ovoca Bio plc Key Details

€0

Revenue

€0

Cost of Revenue

€0

Gross Profit

€3.0k

Other Expenses

-€3.0k

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
-0.000037
0%
0%
0%
View Full Analysis

About OVB

Founded
1985
Employees
1
CEO
Timothy McCutcheon
WebsiteView website
ovocabio.com

Ovoca Bio plc, a clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health. Its lead product is Orenetide, a novel synthetic peptide for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.

Recent OVB News & Updates

Recent updates

No updates